Liv developed a very promising prototype that is now ready for the first clinical tests, which is an important milestone in the R&D process. The acquisition by Cline will advance the development of the product, and I’m confident that it will create great benefits for patients and health care

After three years of being apart of a project that has resulted in the development of Liv Diagnostics, we are very excited to help play an even bigger key role in improving cancer care. Cline will now take over Liv Diagnostics, with the goal to take the company and the project to a point where we can speed up the development of the existing product and reduce fatalities among breast cancer patients

I am excited to be involved in the continued development of this technology together with Cline as we currently have no sure means to treat metastatic disease. With this diagnostic tool we will be in a much better place to accurately diagnose, and thus correctly treat, patients at risk of this devastating disease